1. Home
  2. OGN vs TTAM Comparison

OGN vs TTAM Comparison

Compare OGN & TTAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • TTAM
  • Stock Information
  • Founded
  • OGN 1923
  • TTAM 1902
  • Country
  • OGN United States
  • TTAM Belgium
  • Employees
  • OGN N/A
  • TTAM N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • TTAM
  • Sector
  • OGN Health Care
  • TTAM
  • Exchange
  • OGN Nasdaq
  • TTAM NYSE
  • Market Cap
  • OGN 2.5B
  • TTAM 2.4B
  • IPO Year
  • OGN N/A
  • TTAM 2025
  • Fundamental
  • Price
  • OGN $9.52
  • TTAM $14.68
  • Analyst Decision
  • OGN Hold
  • TTAM Strong Buy
  • Analyst Count
  • OGN 4
  • TTAM 5
  • Target Price
  • OGN $18.00
  • TTAM $17.00
  • AVG Volume (30 Days)
  • OGN 3.5M
  • TTAM 786.2K
  • Earning Date
  • OGN 08-05-2025
  • TTAM 07-29-2025
  • Dividend Yield
  • OGN 0.85%
  • TTAM 0.57%
  • EPS Growth
  • OGN N/A
  • TTAM 169.03
  • EPS
  • OGN 2.88
  • TTAM 0.96
  • Revenue
  • OGN $6,294,000,000.00
  • TTAM $1,626,740,000.00
  • Revenue This Year
  • OGN N/A
  • TTAM $5.60
  • Revenue Next Year
  • OGN $1.11
  • TTAM $8.46
  • P/E Ratio
  • OGN $3.29
  • TTAM $14.68
  • Revenue Growth
  • OGN N/A
  • TTAM 19.25
  • 52 Week Low
  • OGN $8.01
  • TTAM $10.80
  • 52 Week High
  • OGN $23.10
  • TTAM $17.78
  • Technical
  • Relative Strength Index (RSI)
  • OGN 44.17
  • TTAM N/A
  • Support Level
  • OGN $9.53
  • TTAM N/A
  • Resistance Level
  • OGN $10.27
  • TTAM N/A
  • Average True Range (ATR)
  • OGN 0.34
  • TTAM 0.00
  • MACD
  • OGN -0.04
  • TTAM 0.00
  • Stochastic Oscillator
  • OGN 5.49
  • TTAM 0.00

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About TTAM TITAN AMERICA SA

Titan America SA is a vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating on the Eastern Seaboard. The Company, through its wholly owned subsidiaries, operates in the manufacture, distribution, and sale of cement, fly ash, aggregates, ready-mix concrete, and concrete blocks to resellers and construction contractors in the Eastern region of the United States.

Share on Social Networks: